In March, Spain's national food safety agency, AESAN, published nutritional guidelines for menopausal women that were entirely based on studies conducted exclusively on men, according to the New York Post. These recommendations, issued in 2026, aimed to support women through significant physiological changes. However, the foundational research for these critical health recommendations did not represent the target demographic.

Guidelines intended to support women's health during menopause were published, but they were fundamentally flawed by relying on male-only scientific data. Reliance on male-centric studies revealed a profound disconnect within the agency's process, where specific biological needs for women were overlooked. The oversight has called into question the scientific integrity of the initial recommendations.

The Spanish Agency for Food Safety and Nutrition (AESAN) will now review its report on diet and healthy habits during menopause, according to medicalbrief and euronews. The mandated review will likely highlight the pervasive lack of female-specific research in health sciences, pushing for a significant shift towards gender-inclusive study requirements in public health policy.

Understanding the Data Gap in Menopause Nutrition

  • The Spanish Agency for Food Safety and Nutrition (AESAN) did not explicitly warn consumers that the reference studies for its menopause guidelines were conducted only on male populations, according to the New York Post.
  • AESAN acknowledged an 'omission of a warning' regarding the male-only reference studies in its March report, as stated by euronews.
  • Scientists questioned recommendations in the AESAN report because they were based on studies conducted exclusively on men, according to medicalbrief.
  • The review is prompted by scientists questioning recommendations on nutrients for women based on studies conducted exclusively on men, euronews reported.

The agency not only used inappropriate data but also failed to disclose this critical limitation, undermining the scientific integrity of its recommendations. The agency's actions suggest a lack of awareness regarding gender-specific data importance or a deliberate downplaying of a critical flaw. AESAN's reliance on male-only data for women's menopause guidelines isn't just a scientific error; it's a stark reminder that public health institutions globally may still be operating with deeply ingrained gender biases, potentially endangering millions of women.